Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Corporation

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager, Canada

Registration Information

In-house Corporation name: Moderna Biopharma Canada Corporation
Responsible Officer Name: Stefan Raos, General Manager, Canada 
Responsible Officer Change History
Initial registration start date: 2021-07-05
Registration status: Active
Registration Number: 956349-370107

Associated Communications

Total Number of Communication Reports: 64

Monthly communication reports in the last 6 months: 5

Version 7 of 13 (2022-06-14 to 2022-12-13)

Version 7 of 13 (2022-06-14 to 2022-12-13)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Moderna Biopharma Canada Corporation/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Moderna Biopharma Canada Corporation/ 2021-07-05 current

Responsible Officer Change History

Moderna Biopharma Canada Corporation

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)
Stefan Raos 2023-10-19 Current
Patricia Gauthier 2021-07-05 2023-10-19

All Monthly Communication Reports for Moderna Biopharma Canada Corporation

Stefan Raos, General Manager, Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-64 of 64

  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michele Evans, Assistant Deputy Minister, Alberta | Prairies Economic Development Canada (PrairiesCan)

    Subject Matter of the communication: Science and Technology, Economic Development
    Communication date: 2024-01-17
    Posted date: 2024-02-14
    Communication number: 370107-593317 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-12
    Posted date: 2024-01-12
    Communication number: 370107-590330 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joel Dennis, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2023-12-08
    Posted date: 2024-01-12
    Communication number: 370107-590343 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Joel Dennis, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2023-11-08
    Posted date: 2023-12-14
    Communication number: 370107-586141 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Annie Koutrakis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-10-27
    Posted date: 2023-11-14
    Communication number: 370107-581793 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joel Denis, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2023-10-06
    Posted date: 2023-11-14
    Communication number: 370107-581792 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    • Donald Sheppard, Vice President | Public Health Agency of Canada (PHAC)
    • Joel Dennis, Director General | Public Health Agency of Canada (PHAC)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Melissa Sutherland, Director General | Public Health Agency of Canada (PHAC)
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Mollie Royds, Associate Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2023-10-04
    Posted date: 2023-11-14
    Communication number: 370107-581788 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mollie Royds, Associate Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Joel Dennis, Director General | Public Health Agency of Canada (PHAC)
    • Donald Sheppard, Vice President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2023-10-03
    Posted date: 2023-11-14
    Communication number: 370107-581741 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2023-06-07
    Posted date: 2023-07-12
    Communication number: 370107-571675 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister of Innovation, Sciences and Economic Development | Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2023-05-01
    Posted date: 2023-06-13
    Communication number: 370107-568261 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Heather Jeffrey, Associate Deputy Minister | Public Health Agency of Canada (PHAC)
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2023-03-27
    Posted date: 2023-04-13
    Communication number: 370107-561123 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Heather Jeffrey, Associate Deputy Minister | Public Health Agency of Canada (PHAC)
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2023-03-20
    Posted date: 2023-04-13
    Communication number: 370107-562122 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kaili Levesque, Deputy Secretary to the Cabinet | Privy Council Office (PCO)
    • Jacqueline Bogden, Deputy Secretary to the Cabinet | Emergency Preparedness and COVID Recovery | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2023-01-26
    Posted date: 2023-02-13
    Communication number: 370107-555740 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Melissa Sutherland, Director General | Public Health Agency of Canada (PHAC)
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Stephen Bent, Acting Vice-President | Policy, Liaison and Coordination Branch - Vaccine | Public Health Agency of Canada (PHAC)
    • Mollie Royds, Associate Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-12-16
    Posted date: 2023-01-12
    Communication number: 370107-553399 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-12-13
    Posted date: 2023-01-12
    Communication number: 370107-553393 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Harpreet Kochhar, President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-12-13
    Posted date: 2023-01-12
    Communication number: 370107-553390 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Minister for the Federal Economic Development Agency for Southern Ontario | Federal Economic Development Agency for Southern Ontario (FedDev)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-12-13
    Posted date: 2023-01-12
    Communication number: 370107-553375 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2022-12-12
    Posted date: 2023-01-12
    Communication number: 370107-553369 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Bent, Vice-President | Vaccine Rollout Task Force | Public Health Agency of Canada (PHAC)
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Mollie Royds, Associate Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Melissa Sutherland, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-11-24
    Posted date: 2022-12-14
    Communication number: 370107-550581 (amended from 370107-550531) View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Research and Development, Science and Technology
    Communication date: 2022-10-04
    Posted date: 2022-11-08
    Communication number: 370107-545531 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement
    Communication date: 2022-08-31
    Posted date: 2022-09-08
    Communication number: 370107-540901 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-08-30
    Posted date: 2022-09-08
    Communication number: 370107-540896 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Erin Schock, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2022-08-18
    Posted date: 2022-09-08
    Communication number: 370107-540895 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2022-07-06
    Posted date: 2022-08-08
    Communication number: 370107-539215 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Harpreet Kochhar, President | Public Health Agency of Canada (PHAC)
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-07-05
    Posted date: 2022-08-08
    Communication number: 370107-539213 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-06-29
    Posted date: 2022-07-11
    Communication number: 370107-537057 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-06-27
    Posted date: 2022-07-11
    Communication number: 370107-537045 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-06-17
    Posted date: 2022-07-11
    Communication number: 370107-537041 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Harpreet Kochhar, President | Public Health Agency of Canada (PHAC)
    • Theresa Tam, Chief Public Health Officer of Canada | Public Health Agency of Canada (PHAC)
    • Stephen Bent, Acting Vice-President | Policy, Liaison and Coordination Branch - Vaccine | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Research and Development, Science and Technology
    Communication date: 2022-06-16
    Posted date: 2022-07-11
    Communication number: 370107-537018 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Elizabeth Cheesbrough, Chief of Staff | Treasury Board Of Canada Secretariat (TBS)
    • Caitlin Szymberski, Director of Policy | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-06-14
    Posted date: 2022-07-11
    Communication number: 370107-537016 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ian Foucher, Officer | Innovation, Science and Economic Development Canada (ISED)
    • Jean-Sebastien Bock, Director of Policy | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-04-28
    Posted date: 2022-06-17
    Communication number: 370107-536000 (amended from 370107-530802) View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Filomena Tassi, Member of Parliament | House of Commons

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-04-26
    Posted date: 2022-05-09
    Communication number: 370107-530801 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-04-20
    Posted date: 2022-06-16
    Communication number: 370107-535919 (amended from 370107-530800) View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Research and Development, Science and Technology
    Communication date: 2022-04-11
    Posted date: 2022-05-09
    Communication number: 370107-530799 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Theresa Tam, Chief Public Health Officer of Canada | Public Health Agency of Canada (PHAC)
    • Stephen Bent, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)
    • Harpreet Kochhar, President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-04-04
    Posted date: 2022-05-09
    Communication number: 370107-530798 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-03-10
    Posted date: 2022-04-14
    Communication number: 370107-528957 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Harpreet Kochhar, President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development
    Communication date: 2022-03-08
    Posted date: 2022-04-14
    Communication number: 370107-528956 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Boyan Gerasimov, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-02-14
    Posted date: 2022-03-07
    Communication number: 370107-524409 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-02-14
    Posted date: 2022-03-07
    Communication number: 370107-524408 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tasha Stefanis, Director General | Health Canada (HC)
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)
    • Erin Schock, Director General | Public Health Agency of Canada (PHAC)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-01-28
    Posted date: 2022-02-08
    Communication number: 370107-521451 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Stephen Bent, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2022-01-21
    Posted date: 2022-02-08
    Communication number: 370107-521450 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Erin Schock, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-01-10
    Posted date: 2022-02-08
    Communication number: 370107-521449 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)
    • Erin Schock, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-01-07
    Posted date: 2022-02-08
    Communication number: 370107-521448 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Erin Schock, Director General | Public Health Agency of Canada (PHAC)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-01-06
    Posted date: 2022-02-08
    Communication number: 370107-521447 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health, Science and Technology
    Communication date: 2021-12-21
    Posted date: 2022-01-10
    Communication number: 370107-518934 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Filomena Tassi, Minister | Public Services and Procurement Canada (PSPC)
    • Bill Matthews, Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Arianne Reza, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2021-12-20
    Posted date: 2022-01-10
    Communication number: 370107-518933 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health, Science and Technology
    Communication date: 2021-12-17
    Posted date: 2022-01-10
    Communication number: 370107-518932 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health, Science and Technology
    Communication date: 2021-12-10
    Posted date: 2022-01-10
    Communication number: 370107-518931 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Harpreet Kochhar, President | Public Health Agency of Canada (PHAC)
    • Stephen Bent, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2021-12-10
    Posted date: 2022-01-10
    Communication number: 370107-518929 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)
    • Tasha Stefanis, Director General | Health Canada (HC)
    • Colette Downie, Sr. Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Erin Schock, Director, Policy, Governance & Strategic Integration, Centre for Immunization Readiness | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2021-11-24
    Posted date: 2021-12-07
    Communication number: 370107-516634 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-11-17
    Posted date: 2021-12-07
    Communication number: 370107-516633 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Bent, Assistant Deputy Minister | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-16
    Posted date: 2021-12-10
    Communication number: 370107-516991 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-16
    Posted date: 2021-12-07
    Communication number: 370107-516631 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Matthews, Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Filomena Tassi, Member of Parliament | House of Commons
    • Arianne Reza, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement
    Communication date: 2021-10-29
    Posted date: 2021-11-05
    Communication number: 370107-515075 (amended from 370107-515074) View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Bill Matthews, Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Anita Anand, Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement
    Communication date: 2021-10-12
    Posted date: 2021-11-05
    Communication number: 370107-515076 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-08-10
    Posted date: 2021-10-06
    Communication number: 370107-514441 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement
    Communication date: 2021-07-30
    Posted date: 2021-10-06
    Communication number: 370107-514440 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-07-23
    Posted date: 2021-10-06
    Communication number: 370107-514439 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement
    Communication date: 2021-07-22
    Posted date: 2021-10-06
    Communication number: 370107-514438 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-07-16
    Posted date: 2021-10-06
    Communication number: 370107-514437 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-07-15
    Posted date: 2021-10-06
    Communication number: 370107-514436 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-07-14
    Posted date: 2021-10-06
    Communication number: 370107-514435 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joelle Paquette, Director General | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement
    Communication date: 2021-07-12
    Posted date: 2021-10-06
    Communication number: 370107-514434 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-07-07
    Posted date: 2021-10-06
    Communication number: 370107-514430 View associated registration

Monthly Communication Reports in the last 6 Months for Moderna Biopharma Canada Corporation

Stefan Raos, General Manager, Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-64 of 64

  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michele Evans, Assistant Deputy Minister, Alberta | Prairies Economic Development Canada (PrairiesCan)

    Subject Matter of the communication: Science and Technology, Economic Development
    Communication date: 2024-01-17
    Posted date: 2024-02-14
    Communication number: 370107-593317 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-12
    Posted date: 2024-01-12
    Communication number: 370107-590330 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joel Dennis, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2023-12-08
    Posted date: 2024-01-12
    Communication number: 370107-590343 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Joel Dennis, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2023-11-08
    Posted date: 2023-12-14
    Communication number: 370107-586141 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Annie Koutrakis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-10-27
    Posted date: 2023-11-14
    Communication number: 370107-581793 View associated registration

Public offices held:


Date Modified: